CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.-- ...

Many popular proposals to reform the PBM industry are missing the forest for the trees, drug market experts said this week in ...

A U.S. federal judge has ordered CVS Caremark, the pharmacy benefits arm of CVS Health, to pay $95 million over allegations ...

The U.S. secured a partial judgment in its favor on claims that CVS’s pharmacy benefit management subsidiary, Caremark, ...

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...